Skip to main content
Equibles
CRVW logo

CRVW · CareView Communications Inc · Metrics

Track CRVW — free

Use CRVW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.03 +0.00 (+0.00%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company's net losses and working capital deficit raise substantial doubt about the Company's ability to continue as a going concern through August 12, 2027.”
View the 10-Q filed Aug 12, 2026
Market Cap
$17.57M
Shares
583.88M
Volume · Oct 20 10K Avg daily vol (3M) 39.09K

CRVW metrics

71 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.03
Market cap
$17.57M

Price action

20 metrics
Price change (1W)
+0.3%
Price change (30D)
-14.2%
Price change (3M)
-39.8%
Price change (6M)
-24.8%
Price change (YTD)
+201.0%
Price change (1Y)
+0.3%
Trailing year
Price change (5Y)
-81.2%
52-week high
$0.07
52-week low
$0.01
Change from 52-week high
-57.0%
Change from 52-week low
+201.0%
Annualized volatility
286.0%
Annualized volatility (3M)
—
Beta
-0.6
RSI (14D)
41.7
Price vs SMA 50
-21.3%
Price vs SMA 200
-14.5%
Avg volume (3M)
39,671
Relative volume
0.1
Average dollar volume
$1,602

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
583.88M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 53.7%
P / book
—
FCF yield
0.9%
TTM · current market cap
Buyback yield
—
P / FCF
105.8
reciprocal yield 0.9%
P / operating cash flow
87.4
reciprocal yield 1.1%
Earnings yield
-15.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
10.3×
reciprocal yield 9.7%
EV / revenue historical average (5Y)
13.8×
reciprocal yield 7.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
4.4%
Trailing 12 months
Net margin
-28.9%
Gross profit (TTM)
—
Operating profit (TTM)
$418,731
Net income (TTM)
−$2.73M
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
1.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.03
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.00
EBITDA per diluted share (TTM)
$0.00
Net income per diluted share (TTM)
$-0.01
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.01
Stock compensation per diluted share (TTM)
$0.00
Book value per share
$-0.07

Growth

11 metrics
Revenue growth YoY
+19.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$9.44M
Trailing 12 months
EPS growth YoY
-100.0%
Shares change YoY
+318.9%
Year over year · more shares
Revenue CAGR (3Y)
+4.5%
Revenue CAGR (5Y)
+6.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-46.3%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
$565,565
Free cash flow (TTM)
$166,063
Quick ratio
0.1
Interest coverage
0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.92M
Total assets
$5.90M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$201,076
Capital expenditures (TTM)
$35,013
R&D (TTM)
$2.54M
SG&A (TTM)
—
Stock compensation (TTM)
$378,835
R&D / revenue
26.9%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
0
13F filer change QoQ
-1
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 24.3 days to cover
Days to cover
24.3d
Short-squeeze score
37 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1377149 CUSIP 141743104 Visit website